Literature DB >> 18158484

Vasodilators in the management of acute heart failure.

Uri Elkayam1, Munir Janmohamed, Munira Habib, Parta Hatamizadeh.   

Abstract

Recent guidelines by the Heart Failure Society of America have recommended consideration for use of nitroprusside, nitroglycerin, or nesiritide in addition to diuretics to achieve hemodynamic and symptomatic improvement. This article reviews the results of previous studies evaluating the pharmacologic and clinical effects and safety profiles of these drugs in patients with heart failure.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18158484     DOI： 10.1097/01.CCM.0000297161.41559.93

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


  17 in total

Review 1.  Headache-type adverse effects of NO donors: vasodilation and beyond.

Authors:  G Bagdy; P Riba; V Kecskeméti; D Chase; G Juhász
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

2.  Concomitant intravenous nitroglycerin with intracoronary delivery of AAV1.SERCA2a enhances gene transfer in porcine hearts.

Authors:  Ioannis Karakikes; Lahouaria Hadri; Kleopatra Rapti; Dennis Ladage; Kiyotake Ishikawa; Lisa Tilemann; Geng-Hua Yi; Charlotte Morel; Judith K Gwathmey; Krisztina Zsebo; Thomas Weber; Yoshiaki Kawase; Roger J Hajjar
Journal:  Mol Ther       Date:  2012-01-03       Impact factor: 11.454

Review 3.  Medical therapy for acute decompensated heart failure: what recent clinical trials have taught us about diuretics and vasodilators.

Authors:  Catherine Marti; Robert Cole; Andreas Kalogeropoulos; Vasiliki Georgiopoulou; Javed Butler
Journal:  Curr Heart Fail Rep       Date:  2012-03

4.  A nanoparticle delivery vehicle for S-nitroso-N-acetyl cysteine: sustained vascular response.

Authors:  Parimala Nacharaju; Chaim Tuckman-Vernon; Keith E Maier; Jason Chouake; Adam Friedman; Pedro Cabrales; Joel M Friedman
Journal:  Nitric Oxide       Date:  2012-06-15       Impact factor: 4.427

Review 5.  Cardiorenal syndrome: pathophysiology and potential targets for clinical management.

Authors:  Parta Hatamizadeh; Gregg C Fonarow; Matthew J Budoff; Sirous Darabian; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Nat Rev Nephrol       Date:  2012-12-18       Impact factor: 28.314

Review 6.  Current treatment options for early management in acute decompensated heart failure.

Authors:  Jonathan G Howlett
Journal:  Can J Cardiol       Date:  2008-07       Impact factor: 5.223

7.  Dose-dependent benefit of nitroglycerin on microcirculation of patients with severe heart failure.

Authors:  Corstiaan A den Uil; Kadir Caliskan; Wim K Lagrand; Martin van der Ent; Lucia S D Jewbali; Jan P van Kuijk; Peter E Spronk; Maarten L Simoons
Journal:  Intensive Care Med       Date:  2009-07-29       Impact factor: 17.440

Review 8.  Impact of intravenous nitroglycerin in the management of acute decompensated heart failure.

Authors:  Corstiaan A den Uil; Jasper J Brugts
Journal:  Curr Heart Fail Rep       Date:  2015-02

9.  Hemodynamic effects of nitroglycerin ointment in emergency department patients.

Authors:  Bryn E Mumma; Kapil R Dhingra; Charley Kurlinkus; Deborah B Diercks
Journal:  J Emerg Med       Date:  2014-03-31       Impact factor: 1.484

Review 10.  Nitroprusside in decompensated heart failure: what should a clinician really know?

Authors:  Cristina Opasich; Giovanni Cioffi; Alessandra Gualco
Journal:  Curr Heart Fail Rep       Date:  2009-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.